Orchard Therapeutics plc
Hedge Funds Holdings
Last updated:
Orchard Therapeutics plc‘s stocks are currently a part of 22 hedge funds’ portfolios, which represents 29.97% of the total amount of its stocks outstanding. This makes up a total of 3.83M shares of Orchard Therapeutics plc. Compared to the previous quarter, the number fell by -13.55% or -601.21K shares fewer. As for the holding position changes, 145.45% (32) closed the holdings completely. 22 hedge funds are new holders of Orchard Therapeutics plc stock in Q1 2023, it is 100% of total holders.
Hedge funds holding Orchard Therapeutics (Q4 2018 – Q1 2023)
| Q4 2018 | 37 |
|---|---|
| Q1 2019 | 43 |
| Q2 2019 | 68 |
| Q3 2019 | 61 |
| Q4 2019 | 81 |
| Q1 2020 | 74 |
| Q2 2020 | 79 |
| Q3 2020 | 71 |
| Q4 2020 | 75 |
| Q1 2021 | 80 |
| Q2 2021 | 80 |
| Q3 2021 | 76 |
| Q4 2021 | 69 |
| Q1 2022 | 58 |
| Q2 2022 | 47 |
| Q3 2022 | 42 |
| Q4 2022 | 45 |
| Q1 2023 | 22 |
Hedge funds changes in Orchard Therapeutics positions (Q4 2018 – Q1 2023)
| Q4 2018 | 37 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2019 | 11 | 9 | 12 | 5 | 6 |
| Q2 2019 | 30 | 20 | 7 | 5 | 6 |
| Q3 2019 | 12 | 26 | 10 | 18 | -5 |
| Q4 2019 | 29 | 26 | 17 | 9 | 0 |
| Q1 2020 | 13 | 25 | 23 | 19 | -6 |
| Q2 2020 | 18 | 30 | 17 | 13 | 1 |
| Q3 2020 | 11 | 22 | 26 | 18 | -6 |
| Q4 2020 | 14 | 32 | 15 | 10 | 4 |
| Q1 2021 | 19 | 28 | 21 | 14 | -2 |
| Q2 2021 | 13 | 22 | 28 | 13 | 4 |
| Q3 2021 | 12 | 26 | 22 | 15 | 1 |
| Q4 2021 | 17 | 14 | 25 | 23 | -10 |
| Q1 2022 | 8 | 14 | 17 | 18 | 1 |
| Q2 2022 | 7 | 6 | 14 | 17 | 3 |
| Q3 2022 | 8 | 8 | 9 | 13 | 4 |
| Q4 2022 | 9 | 9 | 10 | 4 | 13 |
| Q1 2023 | 22 | 0 | 0 | 32 | -32 |
Hedge funds changes in Orchard Therapeutics stock options (Q4 2018 – Q1 2023)
| Q4 2018 | 0 | 0 |
|---|---|---|
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 63,000 | 254,000 |
| Q4 2020 | 237,000 | 1,055,000 |
| Q1 2021 | 508,000 | 2,006,000 |
| Q2 2021 | 37,000 | 1,242,000 |
| Q3 2021 | 147,000 | 1,245,000 |
| Q4 2021 | 82,000 | 175,000 |
| Q1 2022 | 11,000 | 0 |
| Q2 2022 | 10,000 | 0 |
| Q3 2022 | 6,000 | 0 |
| Q4 2022 | 371 | 0 |
| Q1 2023 | 0 | 0 |